EGM
TTOO

Espalier Global Management’s T2 Biosystems, Inc TTOO Stock Holding History

Espalier Global Management’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-6
Closed -$342K – 89
2015
Q4 		$342K Buy
+6
New +$324K 0.09% 60

Other funds holding TTOO

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
FVFI
Flagship Ventures Fund IV Cambridge, Massachusetts $382M AUM
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Espalier Global Management's TTOO Position: Q1 2016 in Review

Espalier Global Management sold out of T2 Biosystems, Inc (TTOO) in Q1 2016, closing a stake of 6 shares — an estimated $342K sold.

Espalier Global Management first reported a position in TTOO in Q4 2015 and held it in 1 quarter. The position peaked at $342K in Q4 2015. 48 funds tracked by Wall St. Rank hold TTOO as of Q1 2016.

  • Espalier Global Management reported no remaining T2 Biosystems, Inc position as of Q1 2016 after selling out during the quarter.
  • Espalier Global Management sold 6 T2 Biosystems, Inc shares in Q1 2016, an estimated $342K.
  • Espalier Global Management first reported a position in T2 Biosystems, Inc in Q4 2015 and held it in 1 quarter.
  • Espalier Global Management's T2 Biosystems, Inc position peaked at $342K in Q4 2015.
  • 48 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q1 2016.

Based on Espalier Global Management's 13F filing for Q1 2016, filed 16 May 2016.